| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
In the medical imaging industry, the primary function of AI is to assist radiologists and medical professionals by enhancing the accuracy, speed, and efficiency of image analysis. AI helps detect abnormalities (like tumors, fractures, or lesions) in scans such as X-rays, MRIs, and CTs, often earlier and more precisely than manual observation alone. |
AI in medical imaging is fundamentally rooted in the concept of using advanced technology to enhance human capability, achieve diagnostic precision, and reduce clinical errors. These ideas are well-supported by peer-reviewed studies and core principles in both computer science and modern medicine.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI systems assist radiologists by analyzing medical images and highlighting potential abnormalities, which supports decision-making, reduces diagnostic errors, and improves accuracy, especially in complex or borderline cases. |
A key benefit of AI in radiology is that it acts as a second medical opinion by assisting radiologists in interpreting images more accurately and consistently. This concept is supported by the principle of clinical decision support, where AI functions as a collaborative tool rather than a replacement. Studies such as McKinney et al. (2020) in Nature demonstrated that AI could analyze mammograms with accuracy comparable to experts, reinforcing its role in reducing diagnostic errors and supporting physician judgment. This aligns with the idea of augmented intelligence, where AI enhances human decision-making in medical imaging. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy refers to the ability to understand, interpret, and effectively use AI technologies. It involves having foundational knowledge about how AI works, its applications, limitations, and ethical considerations, enabling individuals to interact with AI systems intelligently and responsibly. |
AI literacy refers to the understanding and knowledge of AI technology, enabling individuals to interact with AI systems effectively and responsibly. This concept is supported by digital literacy frameworks (Eshet-Alkalai, 2004) and recent research emphasizing the need for AI-specific competencies, including awareness of AI concepts and ethical implications (Long & Magerko, 2020; Touretzky et al., 2019). These studies highlight that AI literacy is essential for navigating a world increasingly shaped by artificial intelligence. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The correct answer is: **The color of the AI machines**
**Explanation:**
Factors influencing the acceptability of AI among healthcare professionals typically include trust in AI systems, how well AI integrates with existing workflows, understanding of the system, and the professionals' receptiveness to technology. The color or aesthetic design of AI machines is not a recognized factor affecting AI acceptance in healthcare. |
Research on technology acceptance models, such as the Unified Theory of Acceptance and Use of Technology (UTAUT), supports that factors like trust, system understanding, integration with workflows, and technology receptiveness significantly influence healthcare professionals’ acceptance of AI. Studies (e.g., Venkatesh et al., 2003; Gagnon et al., 2016) emphasize that practical and cognitive factors shape adoption, while superficial aspects like the color of machines have no impact on acceptance. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence refers to the impact that colleagues, leaders, and professional networks have on healthcare professionals’ attitudes and decisions regarding adopting AI technologies. It shapes perceptions and acceptance, encouraging or discouraging the use of AI based on shared opinions and social norms within the healthcare community. |
Social influence as a factor in technology acceptance is well supported by the Unified Theory of Acceptance and Use of Technology (UTAUT) developed by Venkatesh et al. (2003), which identifies social influence as a key determinant of users’ intention to adopt new technologies. Research in healthcare settings (e.g., Gagnon et al., 2016) confirms that peer opinions, leadership support, and professional norms significantly impact healthcare professionals’ willingness to use AI, highlighting how social context shapes adoption decisions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A common perceived threat regarding AI usage in healthcare is the fear that AI might replace healthcare professionals, leading to job loss or reduced roles for human experts. This concern affects acceptance and trust in AI technologies within healthcare settings. |
Concerns about AI replacing healthcare professionals are supported by the Technology Acceptance Model (TAM) and studies on AI adoption anxiety, which highlight “job displacement” as a major perceived threat affecting acceptance. Research such as Siau and Wang (2018) emphasizes that fear of automation replacing human roles can lead to resistance among healthcare workers, impacting their willingness to adopt AI technologies despite potential benefits. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
The article emphasizes that to increase AI acceptability among medical professionals, it is essential to design AI systems that focus on human needs, workflows, and collaboration. Human-centred AI prioritizes usability, trust, and seamless integration into clinical practice, which helps healthcare providers feel supported rather than replaced by technology. |
The importance of designing human-centred AI systems is supported by the field of Human-Computer Interaction (HCI) and theories like User-Centered Design (UCD), which emphasize that technology adoption improves when systems are tailored to users’ needs and contexts. Research by Holzinger et al. (2019) highlights that AI in healthcare must be explainable, transparent, and aligned with clinical workflows to build trust and acceptance among medical professionals, ensuring effective collaboration between humans and AI. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
The 'system usage' category of AI acceptability factors includes practical aspects such as the perceived value or benefits of the AI system and how well it integrates with existing clinical workflows. These factors influence whether healthcare professionals find the AI system useful and easy to incorporate into their daily tasks. |
The concept of 'system usage' factors influencing AI acceptability is supported by the Technology Acceptance Model (TAM), which highlights perceived usefulness and ease of integration as key determinants of technology adoption (Davis, 1989). Research in healthcare settings (e.g., Venkatesh et al., 2011) confirms that AI systems are more readily accepted when they clearly demonstrate value to users and fit seamlessly into existing clinical workflows, improving efficiency without disrupting routine practices. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality impacts AI acceptability by influencing whether healthcare professionals perceive AI systems as aligning with their moral and professional values, such as patient privacy, fairness, and accountability. If AI systems are seen as ethically compatible, professionals are more likely to trust and adopt them in clinical practice. |
Ethicality’s role in AI acceptability is supported by the Theory of Planned Behavior (TPB), which suggests that individuals’ attitudes toward a technology—including its alignment with their moral and professional values—significantly influence their intention to use it (Ajzen, 1991). Research in healthcare AI (e.g., Morley et al., 2020) emphasizes that ethical concerns like patient privacy, fairness, and accountability are critical for building trust and acceptance among healthcare professionals, affecting their willingness to adopt AI systems. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
The article emphasizes that future studies on AI acceptability should focus on understanding user experience and how well AI systems integrate into existing clinical workflows. This approach helps identify real-world challenges and improves the design and adoption of AI technologies in healthcare settings. |
The emphasis on user experience and system integration is supported by Human-Computer Interaction (HCI) principles and the Technology Acceptance Model (TAM), which highlight that successful technology adoption depends on usability and seamless workflow integration (Davis, 1989). Research by Gagnon et al. (2016) in healthcare contexts confirms that understanding users’ interactions with AI systems and how these fit into clinical routines is crucial for improving acceptability and sustained use. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
In Parkinson’s disease, the loss of dopamine-producing neurons in the brain leads to motor symptoms. The primary objective of using human embryonic stem cells is to generate new dopamine neurons to replace those that have been lost, thereby restoring dopamine levels and improving motor function. |
The use of human embryonic stem cells (hESCs) to treat Parkinson’s disease is supported by research demonstrating their ability to differentiate into dopamine-producing neurons, which are depleted in the disease. Studies such as Kriks et al. (2011) showed that hESC-derived dopamine neurons can survive transplantation, integrate into the brain, and restore motor function in animal models of Parkinson’s, supporting the therapeutic goal of replacing lost neurons to alleviate symptoms. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
This answer is based on direct information from the preclinical studies for STEM-PD, which explicitly state that rats were used. Rats are a standard and well-established animal model for both safety testing and efficacy studies in Parkinson's disease research. |
Rat models are extensively supported in Parkinson's research as they provide well-characterized models replicating human dopaminergic degeneration and motor deficits. Their suitability for efficacy, safety, and long-term studies makes them a standard and accepted preclinical model for therapies like STEM-PD. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
The 39-week duration for the preclinical safety study in rats for STEM-PD is a specific and crucial factual detail directly derived from the reported design of the product's development. This extended period is typical for GLP (Good Laboratory Practice) safety assessments, which are essential for evaluating potential long-term toxicity, tumorigenicity (tumor formation), and biodistribution of the transplanted cells. Such comprehensive and prolonged studies are a mandatory part of the preclinical data package required by regulatory authorities before a cell-based therapy can proceed to human clinical trials. |
The 39-week duration for preclinical safety studies is mandated by regulatory guidelines (e.g., GLP) for novel cell therapies. This extended period is crucial for comprehensively assessing long-term toxicity, tumorigenicity, and biodistribution, ensuring patient safety by detecting any delayed or chronic adverse effects before human clinical trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
Stating that it is a "first-in-human trial to test the safety and feasibility" (Phase I focus) while also looking for "preliminary signs of efficacy" (Phase IIa focus). It is designed as a dose-escalation trial, which is common in early-phase clinical development. |
Combined Phase I/IIa clinical trials are widely recognized in translational medicine as critical for simultaneously assessing safety and preliminary efficacy of new therapies. Research guidelines from regulatory bodies like the FDA emphasize that this phased approach allows for early detection of adverse effects while providing initial data on therapeutic benefits (Kola & Landis, 2004). In stem cell therapies for Parkinson’s disease, such as STEM-PD, this design ensures patient safety while exploring potential clinical improvements, supporting efficient and ethical clinical development. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM-PD product is manufactured under Good Manufacturing Practice (GMP)-compliant conditions, ensuring that the production process meets strict quality, safety, and regulatory standards required for clinical use. |
Manufacturing stem cell therapies like STEM-PD under Good Manufacturing Practice (GMP) conditions is essential to ensure product quality, safety, and consistency, as required by regulatory agencies such as the FDA and EMA. Research and guidelines (e.g., Gstraunthaler et al., 2014) emphasize that GMP compliance is critical for translating stem cell products from the laboratory to clinical use, minimizing risks of contamination and variability while meeting ethical and legal standards. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The article confirms the safety of the STEM-PD product in rats by reporting that there were no adverse effects or tumor formation observed during the preclinical safety study, indicating the treatment was well tolerated and did not cause harmful side effects.
|
Preclinical safety studies aim to evaluate adverse effects and tumorigenicity, which are critical concerns in stem cell therapies. Research like Kriks et al. (2011) demonstrated that transplantation of human embryonic stem cell-derived dopamine neurons did not result in tumor formation or significant adverse effects in animal models, supporting the importance of thorough safety assessment to ensure clinical viability and patient safety before human trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The efficacy study of STEM-PD in rats showed that the transplanted human embryonic stem cell-derived dopamine neurons survived, integrated into the brain, and reversed motor deficits, demonstrating functional improvement relevant to Parkinson’s disease symptoms. |
Research by Kriks et al. (2011) supports this finding, showing that human embryonic stem cell-derived dopamine neurons transplanted into Parkinson’s disease animal models survived, integrated into the host brain, and effectively reversed motor deficits. This study provides strong evidence that stem cell-based therapies can restore lost neuronal function and improve symptoms in neurodegenerative diseases like Parkinson’s. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
They are fundamental to establishing the midbrain floor plate identity. The assessment would also include checking for the absence of pluripotency markers and other neuronal lineage markers. |
Theory in developmental neurobiology dictates that specific markers like FOXA2 and OTX2 are critical for defining midbrain dopamine neuron progenitors. Research confirms their presence indicates proper differentiation and absence of pluripotency markers ensures safety, forming the basis for reliable purity assessment of STEM-PD. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
Growth factors like FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) are critical in the stem cell differentiation process, guiding cells to develop into specific neural subtypes, such as midbrain dopamine neurons, by influencing cell patterning during manufacturing of the STEM-PD product. |
Research in developmental biology and stem cell differentiation shows that growth factors like FGF8b and SHH play crucial roles in neural patterning by directing pluripotent stem cells toward specific neural fates. Studies such as those by Andersson et al. (2006) demonstrate that these morphogens mimic embryonic signaling cues to induce midbrain dopamine neuron development, which is essential for producing targeted cell types like those used in STEM-PD for Parkinson’s disease therapy. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
These trials specifically aimed to demonstrate that the transplanted cells could integrate into the brain, differentiate into dopamine-producing neurons, and subsequently alleviate the motor deficits characteristic of Parkinson's disease models in rats. |
The theory is rooted in developmental biology, where FGF8b and SHH are known morphogens crucial for patterning the embryonic ventral midbrain. Research consistently shows that by applying these factors in vitro, pluripotent stem cells can be reliably directed to differentiate into midbrain dopaminergic progenitors, mimicking natural development and leading to functional neurons. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|